Last reviewed · How we verify
NCT01273220
National Epidemiologic Survey on Alcohol and Related Conditions-III
trial in Alcohol-Related Disorders in 36,309 participants. Completed in 18 August 2020.
26 September 2013
Quick facts
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36,309 |
| Start date | 7 January 2011 |
| Primary completion | 26 September 2013 |
| Estimated completion | 18 August 2020 |
| Sites | 1 location across United States |
Conditions studied
- Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Who can join
18 and older, any sex, with Alcohol-Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- Alcohol use disorders are the most prevalent mental disorders in the United States and are a factor in more than 10 percent of all deaths, including heart disease, stroke, and certain types of cancer and chronic illness. Research into better treatment methods for alcohol use disorders and their associated disabilities requires a broad amount of information on the genetic and environmental factors that predispose certain individuals to alcoholism. To improve the quality of available information for research, the National Institutes of Health is conducting a nationwide survey on alcohol use disorders and related physical and mental disabilities, and will collect genetic information through saliva samples. Objectives: \- To collect interview data and saliva samples from the U.S. civilian noninstitutionalized population, 18 years and older, in order to study the extent of and contributing factors to alcohol use and abuse in the United States. Eligibility: \- Individuals at least 18 years of age who do not live in institutions (i.e., prisons, inpatient mental hospitals) and who are willing to be interviewed in English, Spanish, and the four most commonly spoken Asian languages in the United States (e.g., Chinese, Korean). Design: * The study will involve three main components: an automated computer-assisted interview, an automated questionnaire, and the collection of a saliva sample. * Participants will be recruited through community through publically available U.S. Census Bureau files. * The interview and questionnaire will ask standardized questions related to personal history; alcohol use and possible disorders; symptoms scales of mood, anxiety, and eating conditions that frequently co-occur with alcohol and drug use disorders; tobacco, medicine and drug use and disorders; selected personality traits, including behavior; alcohol, drug, and mental health treatment utilization; and medical conditions related to alcohol consumption. * Participants will provide a saliva sample for genetic study. Background: \- Alcohol use disorders are the most prevalent mental disorders in the United States and are a factor in more than 10 percent of all deaths, including heart disease, stroke, and certain types of cancer and chronic illness. Research into better treatment methods for alcohol use disorders and their associated disabilities requires a broad amount of information on the genetic and environmental factors that predispose certain individuals to alcoholism. To improve the quality of available information for research, the National Institutes of Health is conducting a nationwide survey on alcohol use disorders and related physical and mental disabilities, and will collect genetic information through saliva samples. Objectives: \- To collect interview data and saliva samples from the U.S. civilian noninstitutionalized population, 18 years and older, in order to study the extent of and contributing factors to alcohol use and abuse in the United States. Eligibility: \- Individuals at least 18 years of age who do not live in institutions (i.e., prisons, inpatient mental hospitals) and who are willing to be interviewed in English, Spanish, and the four most commonly spoken Asian languages in the United States (e.g., Chinese, Korean). Design: * The study will involve three main components: an automated computer-assisted interview, an automated questionnaire, and the collection of a saliva sample. * Participants will be recruited through community through publically available U.S. Census Bureau files. * The interview and questionnaire will ask standardized questions related to personal history; alcohol use and possible disorders; symptoms scales of mood, anxiety, and eating conditions that frequently co-occur with alcohol and drug use disorders; tobacco, medicine and drug use and disorders; selected personality traits, including behavior; alcohol, drug, and mental health treatment utilization; and medical conditions related to alcohol consumption. * Participants will provide a saliva sample for genetic study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Differences in diagnostic rules used to determine borderline personality disorder impact prevalence and associations with clinically relevant variables: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.
Loya JM, Wagner A, Pittman B, Davis MT. · · 2024 · cited 2× · PMID 38206863 · DOI 10.1037/per0000643
Verify or expand the search:
- PubMed search for NCT01273220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol-Related Disorders
Currently open trials in the same condition.
- NCT07039175 — Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease · Phase 3 · recruiting
- NCT06070649 — The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) · Phase 1 · recruiting
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
- NCT07053098 — External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting · NA · recruiting
- NCT06916754 — Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction · NA · recruiting
Other National Institute on Alcohol Abuse and Alcoholism (NIAAA) trials
Trials by the same sponsor.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT06819189 — Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors · Phase 1 · recruiting
- NCT06269627 — Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder · Phase 4 · recruiting
- NCT06484075 — Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01273220 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Last refreshed: 21 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01273220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing